Abstract
It has been almost two years since COVID-19, a disease caused by a new coronavirus called SARS-CoV-2, was declared a pandemic by the World Health Organization. The entire scientific and medical community was put to the test during the following months to find the best therapeutic strategy to save lives. Although some antivirals and anti-inflammatory drugs are being tested in different clinical trials with some controversial results, this short review will focus on corticosteroids usefulness and ventilatory support principles, as they have become two essential therapeutic pillars for those patients who need hospital admission due to respiratory failure.
All Keywords
【초록키워드】 Corticosteroid, COVID-19, SARS-CoV-2, Corticosteroids, Anti-inflammatory drugs, clinical trial, pandemic, Respiratory failure, Antiviral, therapeutic, Patient, Community, Hospital admission, disease, therapeutic strategy, New coronavirus, Health Organization, ventilatory support, World Health Organization, anti-inflammatory drug, tested, caused, 【제목키워드】 SARS-CoV-2, Support, corticosteroid therapy,
【초록키워드】 Corticosteroid, COVID-19, SARS-CoV-2, Corticosteroids, Anti-inflammatory drugs, clinical trial, pandemic, Respiratory failure, Antiviral, therapeutic, Patient, Community, Hospital admission, disease, therapeutic strategy, New coronavirus, Health Organization, ventilatory support, World Health Organization, anti-inflammatory drug, tested, caused, 【제목키워드】 SARS-CoV-2, Support, corticosteroid therapy,
{{{ 추상적인 }}}
SARS-CoV-2라는 신종 코로나바이러스에 의해 발생하는 질병인 COVID-19가 세계보건기구(WHO)에 의해 팬데믹(세계적 대유행)을 선언한 지 거의 2년이 되었습니다. 전체 과학 및 의료계는 생명을 구할 수 있는 최상의 치료 전략을 찾기 위해 다음 달 동안 테스트를 받았습니다. 일부 항바이러스제 및 항염증제가 다양한 임상 시험에서 테스트되어 논란의 여지가 있지만, 이 짧은 리뷰에서는 코르티코스테로이드의 유용성과 인공호흡기 지원 원칙에 초점을 맞출 것입니다. 호흡 부전.